A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma

Henrik Gregersen, Tobias Wirenfeldt Klausen, Niels Abildgaard , Trung Hieu Do, Ida Bruun Kristensen, Ulf Christian Frølund, Niels Frost Andersen, Lene Kongsgaard Nielsen, Christen Lykkegaard Andersen, Annette Juul Vangsted

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdato10. dec. 2017
StatusUdgivet - 10. dec. 2017
Begivenhed59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA 
 - Atlanta, USA
Varighed: 9. dec. 201712. dec. 2017

Konference

Konference59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA 

LandUSA
ByAtlanta
Periode09/12/201712/12/2017

Citer dette

Gregersen, H., Wirenfeldt Klausen, T., Abildgaard , N., Hieu Do, T., Kristensen, I. B., Frølund, U. C., ... Vangsted, A. J. (2017). A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma. Poster session præsenteret på 59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA 
 , Atlanta, USA.
Gregersen, Henrik ; Wirenfeldt Klausen, Tobias ; Abildgaard , Niels ; Hieu Do, Trung ; Kristensen, Ida Bruun ; Frølund, Ulf Christian ; Andersen, Niels Frost ; Kongsgaard Nielsen, Lene ; Lykkegaard Andersen, Christen ; Vangsted, Annette Juul. / A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma. Poster session præsenteret på 59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA 
 , Atlanta, USA.
@conference{18351e64a5964004b2e6633fe7e6067c,
title = "A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma",
author = "Henrik Gregersen and {Wirenfeldt Klausen}, Tobias and Niels Abildgaard and {Hieu Do}, Trung and Kristensen, {Ida Bruun} and Fr{\o}lund, {Ulf Christian} and Andersen, {Niels Frost} and {Kongsgaard Nielsen}, Lene and {Lykkegaard Andersen}, Christen and Vangsted, {Annette Juul}",
year = "2017",
month = "12",
day = "10",
language = "English",
note = "null ; Conference date: 09-12-2017 Through 12-12-2017",

}

Gregersen, H, Wirenfeldt Klausen, T, Abildgaard , N, Hieu Do, T, Kristensen, IB, Frølund, UC, Andersen, NF, Kongsgaard Nielsen, L, Lykkegaard Andersen, C & Vangsted, AJ 2017, 'A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma', 59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA 
 , Atlanta, USA, 09/12/2017 - 12/12/2017.

A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma. / Gregersen, Henrik; Wirenfeldt Klausen, Tobias; Abildgaard , Niels; Hieu Do, Trung ; Kristensen, Ida Bruun; Frølund, Ulf Christian; Andersen, Niels Frost; Kongsgaard Nielsen, Lene; Lykkegaard Andersen, Christen; Vangsted, Annette Juul.

2017. Poster session præsenteret på 59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA 
 , Atlanta, USA.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

TY - CONF

T1 - A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma

AU - Gregersen, Henrik

AU - Wirenfeldt Klausen, Tobias

AU - Abildgaard , Niels

AU - Hieu Do, Trung

AU - Kristensen, Ida Bruun

AU - Frølund, Ulf Christian

AU - Andersen, Niels Frost

AU - Kongsgaard Nielsen, Lene

AU - Lykkegaard Andersen, Christen

AU - Vangsted, Annette Juul

PY - 2017/12/10

Y1 - 2017/12/10

M3 - Poster

ER -

Gregersen H, Wirenfeldt Klausen T, Abildgaard N, Hieu Do T, Kristensen IB, Frølund UC et al. A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma. 2017. Poster session præsenteret på 59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA 
 , Atlanta, USA.